IMUGENE LIMITED — Share Issue/Capital Change 2022

Apr 11, 2022

==> picture [116 x 41] intentionally omitted <==

ASX Announcement

Release of Shares from Escrow

---

SYDNEY, Australia, 12 April 2022: Imugene Limited (ASX: IMU), an immuno-oncology company, in accordance with ASX listing rule 3.10A, advises that 28,328,452 ordinary fully paid shares (ASX: IMU) will be released from voluntary escrow on 22 April 2022.

Phillip Hains Joint Company Secretary

IMUGENE LIMITED ACN 009 179 551 WWW.IMUGENE.COM info@imugene.com